These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 4800219)

  • 1. [Treatment of myeloproliferative diseases].
    Burkhardt R
    Munch Med Wochenschr; 1973 May; 115(19):878-91. PubMed ID: 4800219
    [No Abstract]   [Full Text] [Related]  

  • 2. [The treatment of myeloproliferative syndromes].
    Maurice P
    Schweiz Med Wochenschr; 1975 Oct; 105(40):1269-74. PubMed ID: 1061995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood and neoplastic diseases. Myeloproliferative disorders.
    Lewis SM; Szur L
    Br Med J; 1974 Nov; 4(5941):399-402. PubMed ID: 4425895
    [No Abstract]   [Full Text] [Related]  

  • 4. Myeloproliferative diseases in childhood.
    Nix WL; Fernbach DJ
    Am J Pediatr Hematol Oncol; 1981; 3(4):397-407. PubMed ID: 6174053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Present treatment of the Vaquez's disease].
    Vallée G; Boivin P; Dormont J; Soulier JP
    Presse Med (1893); 1969 Mar; 77(14):517-9. PubMed ID: 5783371
    [No Abstract]   [Full Text] [Related]  

  • 6. Management and therapy of polycythaemia vera.
    Israëls MC
    Br J Haematol; 1969 Sep; 17(3):305. PubMed ID: 5257763
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of polycythaemia vera with reinfusion of autologous blood plasma obtained by phlebotomy.
    Stefanović S; Radotić M; Dukić M; Ristić M; Banićević B; Jancić MS; Maslovarić S
    Haematologia (Budap); 1974; 8(1-4):473-6. PubMed ID: 4461432
    [No Abstract]   [Full Text] [Related]  

  • 8. [Presentation of 3 cases of anaphylactic shock. Considerations on prognosis and treatment].
    Carassai P; Damia GV; Sibilla E
    Minerva Anestesiol; 1966 Oct; 32(10):555-7. PubMed ID: 4869304
    [No Abstract]   [Full Text] [Related]  

  • 9. Some uses of the continuous flow blood separator in the myeloproliferative syndrome.
    Bell R; Sullivan JR; Hurley TH; D'Apice AJ; Kincaid-Smith P
    Aust N Z J Med; 1978 Aug; 8(4):433-5. PubMed ID: 282861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The management of elderly patients with myeloproliferative disorders.
    Tura S
    Hematol Oncol; 1993; 11 Suppl 1():39-41. PubMed ID: 8486340
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies on the phagocytic activity of neutrophilic leukocytes.
    Brandt L
    Scand J Haematol Suppl; 1967; 2():1-126. PubMed ID: 5243720
    [No Abstract]   [Full Text] [Related]  

  • 12. A fifteen-year cytogenetic remission following interferon treatment in a patient with an indolent ETV6-ABL positive myeloproliferative syndrome.
    Mozziconacci MJ; Sainty D; Chabannon C
    Am J Hematol; 2007 Jul; 82(7):688-9. PubMed ID: 17366548
    [No Abstract]   [Full Text] [Related]  

  • 13. [Therapy of polycythemia vera].
    Stecher G; Hennemann HH
    Minerva Med; 1969 Oct; 60(87):4351-3. PubMed ID: 5354514
    [No Abstract]   [Full Text] [Related]  

  • 14. Platelet function after busulphan in chronic myeloproliferative disorders.
    Barbui T; Bassan R; Viero P; Cortelazzo S; Dini E
    Haematologica; 1983; 68(4):469-77. PubMed ID: 6414897
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of myeloproliferative diseases.
    Sellei C
    Ther Hung; 1966; 14(4):135-6. PubMed ID: 5228101
    [No Abstract]   [Full Text] [Related]  

  • 16. [Preleukemic states].
    Vacarezza R
    Rev Med Chil; 1982 Jul; 110(7):679-86. PubMed ID: 6296959
    [No Abstract]   [Full Text] [Related]  

  • 17. [Choice of therapy and overall survival in patients with chronic myeloproliferative diseases].
    Rukavitsyn OA; Pop VP; Seriakov AP
    Vopr Onkol; 2004; 50(4):435-9. PubMed ID: 15605767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Administration of corticosteroids in hematologic diseases].
    Haanen C
    Ned Tijdschr Geneeskd; 1978 May; 122(19):671-8. PubMed ID: 652084
    [No Abstract]   [Full Text] [Related]  

  • 19. [Polycythemia vera: therapeutic use of busulfan. Comparison with radioactive phosphorous].
    Jamra M; Verrastro T
    Rev Hosp Clin Fac Med Sao Paulo; 1967; 22():Suppl:241-66. PubMed ID: 5629089
    [No Abstract]   [Full Text] [Related]  

  • 20. An unusual case of myeloproliferative disease which started with erythroderma: chronic (incomplete) panmyelosis.
    Gorini M; Ghizzi A; Bobbio Pallavicini E; Perugini S
    Haematologica; 1979 Dec; 64(6):804-11. PubMed ID: 161880
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.